Dr Alice Jackson

  • Honorary Clinical Lecturer (Institute of Cardiovascular & Medical Sciences)

email: Alice.Jackson@glasgow.ac.uk

Cardiology Dept, Queen Elizabeth University Hospital, 1345 Govan Road, G51 4TF

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020 | 2019 | 2018
Number of items: 19.

2022

Wijkman, M. O. et al. (2022) Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials. Cardiovascular Diabetology, 21(1), 110. (doi: 10.1186/s12933-022-01545-1) (PMID:35717169)

Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S. , Petrie, M. C. , Dahlström, U., McMurray, J. J.V. and Lund, L. H. (2022) Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. JACC: Heart Failure, 10(6), pp. 380-392. (doi: 10.1016/j.jchf.2022.04.006) (PMID:35654522)

Curtain, J. P. et al. (2022) Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. European Journal of Heart Failure, 24(3), pp. 551-561. (doi: 10.1002/ejhf.2419) (PMID:34969175)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24(3), pp. 497-509. (doi: 10.1002/ejhf.2403) (PMID:34918855)

2021

Jackson, A. M. et al. (2021) Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. European Journal of Heart Failure, 23(12), pp. 2058-2069. (doi: 10.1002/ejhf.2264) (PMID:34114268)

Jackson, A. M. et al. (2021) Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal, 42(36), pp. 3741-3752. (doi: 10.1093/eurheartj/ehab499) (PMID:34392331) (PMCID:PMC8455346)

Docherty, K. F. et al. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144(3), pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892) (PMID:33983794)

2020

Dewan, P. et al. (2020) The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure, 22(11), pp. 2123-2133. (doi: 10.1002/ejhf.1832) (PMID:32353205)

Jackson, A. M. et al. (2020) Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF. Circulation, 142(11), pp. 1040-1054. (doi: 10.1161/CIRCULATIONAHA.120.047077) (PMID:32673497) (PMCID:PMC7664959)

Dewan, P. , Jackson, A., Lam, C. S.P., Pfeffer, M. A., Zannad, F., Pitt, B., Solomon, S. D. and McMurray, J. J.V. (2020) Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure. European Journal of Heart Failure, 22(5), pp. 898-901. (doi: 10.1002/ejhf.1776) (PMID:32115864)

Jackson, A. M. et al. (2020) Healthcare disparities for women hospitalised with myocardial infarction and angina. European Heart Journal: Quality of Care and Clinical Outcomes, 6(2), pp. 156-165. (doi: 10.1093/ehjqcco/qcz040) (PMID:31346604) (PMCID:PMC7132925)

Serenelli, M. et al. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8(3), pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011) (PMID:31926854) (PMCID:PMC7086149)

McMurray, J. J.V. et al. (2020) Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF. Circulation, 141(5), pp. 338-351. (doi: 10.1161/CIRCULATIONAHA.119.044491) (PMID:31736337)

Ford, T. J. et al. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95(2), pp. 232-241. (doi: 10.1002/ccd.28373) (PMID:31264314) (PMCID:PMC7027486)

2019

Jackson, A. M. and Jhund, P. S. (2019) The price of a failing heart. European Journal of Heart Failure, 21(12), pp. 1532-1533. (doi: 10.1002/ejhf.1605) (PMID:31815336)

Bauersachs, J. et al. (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21(7), pp. 827-843. (doi: 10.1002/ejhf.1493) (PMID:31243866)

Jackson, A. M. and Jhund, P. S. (2019) Heart failure with reduced ejection fraction. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 383-395. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_36)

2018

Sliwa, K., Petrie, M. C. , Hilfiker-Kleiner, D., Mebazaa, A., Jackson, A., Johnson, M. R., van der Meer, P., Mbakwem, A. and Bauersachs, J. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 20(6), pp. 951-962. (doi: 10.1002/ejhf.1178) (PMID:29578284)

Jackson, A. M., Dalzell, J. R., Walker, N. L., Coats, C. J. , Jhund, P. S. and Petrie, M. C. (2018) Peripartum cardiomyopathy: diagnosis and management. Heart, 104(9), pp. 779-786. (doi: 10.1136/heartjnl-2016-310599) (PMID:29122930)

This list was generated on Sun Jun 26 23:20:39 2022 BST.
Number of items: 19.

Articles

Wijkman, M. O. et al. (2022) Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials. Cardiovascular Diabetology, 21(1), 110. (doi: 10.1186/s12933-022-01545-1) (PMID:35717169)

Jackson, A. M., Benson, L., Savarese, G., Hage, C., Jhund, P. S. , Petrie, M. C. , Dahlström, U., McMurray, J. J.V. and Lund, L. H. (2022) Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF Registry. JACC: Heart Failure, 10(6), pp. 380-392. (doi: 10.1016/j.jchf.2022.04.006) (PMID:35654522)

Curtain, J. P. et al. (2022) Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. European Journal of Heart Failure, 24(3), pp. 551-561. (doi: 10.1002/ejhf.2419) (PMID:34969175)

Jackson, A. M. et al. (2022) Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, 24(3), pp. 497-509. (doi: 10.1002/ejhf.2403) (PMID:34918855)

Jackson, A. M. et al. (2021) Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. European Journal of Heart Failure, 23(12), pp. 2058-2069. (doi: 10.1002/ejhf.2264) (PMID:34114268)

Jackson, A. M. et al. (2021) Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal, 42(36), pp. 3741-3752. (doi: 10.1093/eurheartj/ehab499) (PMID:34392331) (PMCID:PMC8455346)

Docherty, K. F. et al. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144(3), pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892) (PMID:33983794)

Dewan, P. et al. (2020) The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. European Journal of Heart Failure, 22(11), pp. 2123-2133. (doi: 10.1002/ejhf.1832) (PMID:32353205)

Jackson, A. M. et al. (2020) Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF. Circulation, 142(11), pp. 1040-1054. (doi: 10.1161/CIRCULATIONAHA.120.047077) (PMID:32673497) (PMCID:PMC7664959)

Dewan, P. , Jackson, A., Lam, C. S.P., Pfeffer, M. A., Zannad, F., Pitt, B., Solomon, S. D. and McMurray, J. J.V. (2020) Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure. European Journal of Heart Failure, 22(5), pp. 898-901. (doi: 10.1002/ejhf.1776) (PMID:32115864)

Jackson, A. M. et al. (2020) Healthcare disparities for women hospitalised with myocardial infarction and angina. European Heart Journal: Quality of Care and Clinical Outcomes, 6(2), pp. 156-165. (doi: 10.1093/ehjqcco/qcz040) (PMID:31346604) (PMCID:PMC7132925)

Serenelli, M. et al. (2020) Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction. JACC: Heart Failure, 8(3), pp. 188-198. (doi: 10.1016/j.jchf.2019.09.011) (PMID:31926854) (PMCID:PMC7086149)

McMurray, J. J.V. et al. (2020) Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF. Circulation, 141(5), pp. 338-351. (doi: 10.1161/CIRCULATIONAHA.119.044491) (PMID:31736337)

Ford, T. J. et al. (2020) Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheterization and Cardiovascular Interventions, 95(2), pp. 232-241. (doi: 10.1002/ccd.28373) (PMID:31264314) (PMCID:PMC7027486)

Jackson, A. M. and Jhund, P. S. (2019) The price of a failing heart. European Journal of Heart Failure, 21(12), pp. 1532-1533. (doi: 10.1002/ejhf.1605) (PMID:31815336)

Bauersachs, J. et al. (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21(7), pp. 827-843. (doi: 10.1002/ejhf.1493) (PMID:31243866)

Sliwa, K., Petrie, M. C. , Hilfiker-Kleiner, D., Mebazaa, A., Jackson, A., Johnson, M. R., van der Meer, P., Mbakwem, A. and Bauersachs, J. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 20(6), pp. 951-962. (doi: 10.1002/ejhf.1178) (PMID:29578284)

Jackson, A. M., Dalzell, J. R., Walker, N. L., Coats, C. J. , Jhund, P. S. and Petrie, M. C. (2018) Peripartum cardiomyopathy: diagnosis and management. Heart, 104(9), pp. 779-786. (doi: 10.1136/heartjnl-2016-310599) (PMID:29122930)

Book Sections

Jackson, A. M. and Jhund, P. S. (2019) Heart failure with reduced ejection fraction. In: Touyz, R. M. and Delles, C. (eds.) Textbook of Vascular Medicine. Springer: Cham, pp. 383-395. ISBN 9783030164805 (doi: 10.1007/978-3-030-16481-2_36)

This list was generated on Sun Jun 26 23:20:39 2022 BST.